We are live on
!
Find out more
NRC
North Run Capital Portfolio holdings
AUM
$43.5M
1-Year Est. Return
38.24%
This Fund
S&P 500
This Quarter
Est. Return
-5.04%
1 Year Est. Return
-38.24%
3 Year Est. Return
+19.43%
5 Year Est. Return
+17.57%
10 Year Est. Return
–
AUM
$181M
AUM Growth
+$17.1M
(+10%)
Cap. Flow
+$34.4M
Cap. Flow
% of AUM
19.02%
Top 10 Holdings %
Top 10 Hldgs %
77.38%
Holding
21
New
6
Increased
4
Reduced
7
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Magnachip Semiconductor
MX
|
+$14M |
| 2 |
Celestica
CLS
|
+$12M |
| 3 |
JELD-WEN Holding
JELD
|
+$9.79M |
| 4 |
CYBR
CyberArk
CYBR
|
+$8.07M |
| 5 |
Willis Towers Watson
WTW
|
+$7.85M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
IMPV
Imperva, Inc.
IMPV
|
+$12.4M |
| 2 |
Constellium
CSTM
|
+$3.11M |
| 3 |
Crocs
CROX
|
+$2.84M |
| 4 |
NWY
New York & Co Inc
NWY
|
+$2.42M |
| 5 |
Red Rock Resorts
RRR
|
+$740K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.36% |
| 2 | Consumer Discretionary | 18.72% |
| 3 | Healthcare | 13.93% |
| 4 | Financials | 9.99% |
| 5 | Materials | 6.27% |
Similar funds
ACM
HA
JI
CCS
BGP
EOCM
SJIA
LN
North Run Capital's Q1 2018 Portfolio in Review
As of Q1 2018, North Run Capital held 21 positions worth $181M, up 10% from $164M the previous quarter. Its ten largest holdings account for 77% of the portfolio.
North Run Capital deployed $34.4M of net new capital in Q1 2018, opening 6 new positions and adding to 4 existing holdings. Its largest new stake was Celestica: 1,115,000 shares worth $11.5M.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 23% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Imperva, Inc., an estimated $12.4M trimmed.
- North Run Capital's largest Q1 2018 buy was Celestica: 1,115,000 shares worth $11.5M.
- North Run Capital added most to Magnachip Semiconductor in Q1 2018, an estimated $14M increase.
- North Run Capital's biggest Q1 2018 reduction was Imperva, Inc., cutting an estimated $12.4M.
- North Run Capital fully exited Crocs in Q1 2018, selling an estimated $2.84M.
- North Run Capital's ten largest holdings make up 77% of its $181M portfolio in Q1 2018.
- North Run Capital opened 6 new positions and closed 3 in Q1 2018.
- North Run Capital's portfolio value rose 10% quarter-over-quarter to $181M.
Based on North Run Capital's 13F filing for Q1 2018, filed 11 May 2018.